Comparison Between Intrathecal and Intravenous Dexmedetomidine

• Status: Completed
• Trial end date: 2020-03-30
• Target enrollment: 0
• Participant gender: All

Summary

A prospective, randomized, comparative controlled clinical trial, aiming to compare the use of intrathecal dexmedetomidine by intravenous dexmedetomidine in concern of the first request to analgesia. The secondary end-points were the total postoperative analgesic consumption as well as the VAS.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Suez Canal University
• Treatments: Dexmedetomidine

Criteria

Inclusion Criteria:

• ASA I-II patients

• age 18-65 years

• scheduled for lower limb surgery

• spinal anaesthesia

Exclusion Criteria:

• patients with coagulopathy

• infection at the site of lumbar puncture

• beta-blockers or calcium channel blockers usage

• hypersensitivity to Bupivacaine or Dexmedetomidine

• any other contra-indications for spinal anaesthesia.